fda semaglutide compounding warning november 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of July 29, 2024: FDA issued

This comprehensive approach explains broad research applications across skin health studies

Suzanne Moyer Thanks, Veeneta, and, glad to be here

This drug combination may cause serious side effects, which is why you should only take them together if your healthcare provider instructs you to do so

This is vital not only for people who have fish odor syndrome, but also because TMA can accelerate atherosclerosis and heart disease

The Phase 2 trial data did not report a significant increase in clinically relevant arrhythmias, but this is an area of ongoing safety monitoring.

68-70 There are few other studies in humans assessing this effect